The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OBI-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia A

被引：0
|
作者：
Farin, Heinrich D. [1 ]
Novack, Aaron [1 ]
Mo, Min [1 ]
Bourgeois, Christelle [2 ]
Horling, Frank M. [2 ]
Ewenstein, Bruce M. [1 ]
机构：
[1] Baxter Healthcare Corp, Westlake Village, CA USA
[2] Baxter BioSci, Vienna, Austria
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS (vol 15, 20406207241260332, 2024)
    Miesbach, W.
    Curry, N.
    Knoebl, P.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [32] Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII? (Sep, 10.1055/a-1171-0522, 2020)
    Tiede, A.
    HAMOSTASEOLOGIE, 2021, 41 (04): : E1 - E1
  • [33] THE USE OF PORCINE FACTOR-VIII IN THE TREATMENT OF PATIENTS WITH ACQUIRED HEMOPHILIA - THE UNITED-KINGDOM EXPERIENCE
    MORRISON, AE
    LUDLAM, CA
    AMERICAN JOURNAL OF MEDICINE, 1991, 91 : S23 - S26
  • [34] Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII
    Kenet, G
    Lubetsky, A
    Gitel, S
    Luboshitz, J
    Varon, D
    Martinowitz, U
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S35 - S38
  • [35] Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors
    Stephens, Jennifer M.
    Joshi, Ashish V.
    Sumner, Michael
    Botteman, Marc F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (08) : 1127 - 1136
  • [36] Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study
    Ma, Alice D.
    Kessler, Craig M.
    Al-Mondhiry, Hamid A. B.
    Gut, Robert Z.
    Cooper, David L.
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 753 - 760
  • [37] The in vitro cross-reactivity and blood coagulation potential of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
    Takeyama, Masahiro
    Sasai, Kana
    Miyaguchi, Yasuo
    Ogiwara, Kenichi
    Furukawa, Shoko
    Shimonishi, Naruto
    Nakajima, Yuto
    Ueda, Hitoshi
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (01) : 45 - 55
  • [38] Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII
    Liebman, HA
    Chediak, J
    Fink, KI
    Galvez, AG
    Shah, PC
    Sham, RL
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 63 (03) : 109 - 113
  • [39] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Curry, N.
    Knoebl, P.
    Percy, C.
    Santoro, R.
    Schmaier, A. H.
    Trautmann-Grill, K.
    Badejo, K.
    Chen, J.
    Nouri, M.
    Oberai, P.
    Klamroth, R.
    HAEMOPHILIA, 2023, 29 : 101 - 102
  • [40] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Knoebl, P.
    Santoro, R.
    Chen, J.
    Tripkovic, N.
    Percy, C. L.
    Schmaier, A. H.
    Klamroth, R.
    HAEMOPHILIA, 2021, 27 : 119 - 119
12345